Clinical Evaluation of Efficacy and Safety of FS VH S/D 500 S-APR for Hemostasis in Subjects Undergoing Vascular Surgery

Grants and Contracts Details

StatusFinished
Effective start/end date6/26/095/31/11

Funding

  • Baxter Healthcare Co: $52,411.00